RecruitingNCT05142735
N-acetylcysteine or placebo for early signs linked to psychosis
About this title
Read the official source — NCT05142735Placebo comparisonAges 16–35CanadaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 16 years to 35 years.
- Listed locations
- TorontoSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 13, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 90
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Dietary supplement
- Locations
- Canada
- Age range
- From 16 Years to 35 Years
- Official registry ID
- NCT05142735
- Official title
Show the full official title
Effects of N-acetylcysteine on Psychosis-like Symptoms and a Neurophysiological Biomarker of the Clinical High Risk for Schizophrenia
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Who can participate?
Listed age limits: 16 years to 35 years.
Is this study still recruiting?
The registry lists this study as recruiting.
